<DOC>
	<DOCNO>NCT02087189</DOCNO>
	<brief_summary>This clinical investigation design confirm safety efficacy TD01 ICD lead .</brief_summary>
	<brief_title>TD01 Master Study ( Safety Efficacy Study )</brief_title>
	<detailed_description />
	<criteria>Meet standard indication ICD/CRTD therapy First ICD/CRTD implantation upgrade pacemaker Duly sign informed consent form Willing participate whole study duration Patient accept Home Monitoring concept able activate use CardioMessenger Patient legal capacity ability consent Meet standard contraindication ICD/CRTD therapy Age &lt; 18 year Pregnant breastfeeding Cardiac surgery plan within next six month Enrollment another cardiac clinical investigation active treatment arm Mechanical tricuspid valve prosthesis severe tricuspid valve disease Known dexamethasone acetate intolerance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>ICD , CRT-D , lead</keyword>
</DOC>